# FDA recall D-1090-2014

> **Gilead Sciences, Inc.** · Class III · drug recall initiated 2014-02-19.

## Product

Atripla (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) Tablets, 30 Tablet Bottles, Rx only.  Manufactured for: Bristol-Myers Squibb & Gilead Sciences, LLC, Foster City, CA 94404.  Made in Ireland. NDC 15584-0101-1.    Manufactured for:  Bristol-Myers-Squibb & Gilead Sciences, LLC,  Foster City, CA 94404  Made in Ireland

## Reason for recall

Presence of Foreign Substance: Red Silicone Rubber Particulates are Present in Drug.

## Distribution

Nationwide including Puerto Rico.

## Key facts

- **Recall number:** D-1090-2014
- **Recalling firm:** Gilead Sciences, Inc.
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2014-02-19
- **Report date:** 2014-03-05
- **Termination date:** 2015-05-11

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Foster City, CA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1090-2014

## Citation

> AI Analytics. FDA recall D-1090-2014. Retrieved 2026-06-23 from https://api.ai-analytics.org/recall/D-1090-2014. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*